Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program. J of Skin [Internet]. 2025 Mar. 17 [cited 2025 Oct. 25];9(2):s561. Available from: https://skin.dermsquared.com/skin/article/view/3291